Massive saddle pulmonary embolism during radiochemotherapy of head and neck cancer.

A. Nobis,Elżbieta Sierko,B. Kasprowicz,Stefan Jelski,M. Wojtukiewicz,E. Sierko

DOI: https://doi.org/10.20452/pamw.4080

2017-08-07

Polish Archives of Internal Medicine

Abstract:561 Thromboembolic complications (TC) are common in the course of some cancers, such as lung, gastrointestinal, and gynecologic cancers, as well as brain tumors.1 Surgical treatment of patients with head and neck cancer is an important risk factor for TC.2,3 However, data on the incidence of TC in nonsurgically treated patients with head and neck cancer are scarce. A 65-year-old patient with low-differentiated carcinoma (FIGURE 1A–1C) of the head and neck region, with multiple bilateral metastatic lymph nodes in the neck (TxN3M0 according to the TNM classification; FIGURE 1D–1F), was hospitalized to undergo megavoltage 3-dimensional radiotherapy (70 Gy/35 fractions delivered in 7 weeks) with 3 courses of concomitant chemotherapy. The comorbidities included type 2 diabetes, arterial hypertension, and obesity. From the beginning of the therapy, the patient showed fluctuating glucose levels; therefore, insulin therapy along with the regulation and close monitoring of blood glucose levels were introduced. Because of persistent vomiting, the patient was administered antiemetic agents, parenteral hydration, and electrolyte supplementation. He remained mobile. After 2 weeks of radiotherapy, he developed a progressive acute inflammatory radiation reaction in the mucous and skin of the head and neck CLINICAL IMAGE